Patent ID: 11939572
Assignee: ETH ZüRICH
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C  G

Claim 3:
4. The method according to claim 1 or 2, wherein:
(a) the extracellular part of the MHC class I alpha chain of the first polypeptide comprises an MHC class I alpha 1 domain, an MHC class I alpha 2 domain, and an MHC class I alpha 3 domain; or
(b) the extracellular part of the MHC class II alpha chain of the first polypeptide comprises an MHC class II alpha 1 domain and an MHC class II alpha 2 domain, and the extracellular part of the MHC class II beta chain of the second polypeptide comprises an MHC class II beta 1 domain and an MHC class II beta 2 domain.